Clinical Trial Update: Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating celecoxib for metastatic or recurrent breast cancer in women has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED